In the January/February issue of PM360, David Fleishman joins other industry thought leaders to share their thoughts on how to make the clinical trial process more efficient, easier and accessible to a wider group of patients.
In the January/February issue of PM360, David Fleishman joins other industry thought leaders to share their thoughts on how to make the clinical trial process more efficient, easier and accessible to a wider group of patients.
Topics: Patient Experience, David Fleishman, PM360, Diversity, Equity and Inclusion
Breakthrough Clinical Trial Support System Establishes a New Standard in Engagement
BBK Worldwide (BBK), the global leader in maximizing the clinical trial experience for patients and providers, today announced the launch of TCN® Engage, a breakthrough engagement ecosystem dedicated to providing a full array of visit support services from the time a patient responds to an advertisement for a clinical trial opportunity through to their completion of the study.
Topics: Technology, Most Viewed, Joan F. Bachenheimer, Rob Laurens, Press Release, TCN Engage, Concierge Support
Clinical trial patient recruitment saw a lot of advancements in 2022, from patient concierge programs to DEI enrollment strategies. But what’s in store for 2023? We asked six of our industry experts to weigh in with their predictions.
Topics: Most Viewed, Rob Laurens, Aaron Fleishman, Elizabeth Gargill, Crystal Ball, Michael Turner, 2023 Predictions, Andre Briola, Erica Mercado
We are very excited to kick off the new year with the announcement that we have been acquired by Publicis Health, the healthcare communications leader that transforms healthcare marketing and communications into healthcare engagement.
Together, we share a commitment to the clinical trial experience and to enhancing understanding and access for all, and we look forward to joining the Publicis Health network. Our mission remains unchanged, as does our commitment to supporting you in advancing your clinical R&D efforts.
Topics: Most Viewed, Joan F. Bachenheimer, Publicis Health, Alexandra von Plato
BBK Worldwide Launches the Engagement Solution Center for Decentralized and Post-Marketing Clinical Trial Success
Concierge Service Delivery and Robust Patient Experience Portal Ease Clinical Trial Journey
The COVID-19 pandemic has significantly accelerated the need to reshape research and development. Most specifically, it has led to demand for increased funding for decentralized and larger randomized clinical trials to inform clinical decisions and guide future research.
By launching the Engagement Solution Center, BBK Worldwide (BBK) is making patient-centric and inclusive trials an immediate and actionable reality for study sponsors.
Topics: TrialCentralNet, Rob Laurens, Decentralized Trials, Engagement Solution Center, Patient Centric, Post-Marketing
Ever wonder which products and services study sponsors are leveraging for enrollment and engagement success? We thought we would take a moment to share the products and services gaining traction with our clients who are embracing decentralized clinical trials. And while it's always important to keep in mind that each study protocol is unique and requires its own analysis to determine the right solutions, we're sharing three popular ones below.
Topics: Patient Reimbursement, Decentralized Trials, Medication Delivery, In-home Nurse Visits, Mobile Wallet
We recently sat down with BBK’s Global Strategist Amanda Moody to discuss the company’s commitment to Parkinson’s disease clinical research, including ongoing innovation designed to foster a positive and meaningful patient journey.
Can you briefly describe BBK’s experience with the Parkinson’s disease community?
We have a long-standing commitment to the Parkinson’s community, both in terms of supporting clinical research as well as individual patient and caregiver needs.
Topics: RSG Arrive, RSG Card, Parkinson's disease, The Michael J. Fox Foundation, Amanda Moody, Parkinson's Disease Therapeutics Webinars